SCHEMBL14329571

SCHEMBL14329571

c1ccc(-n2c3cccnc3c3c4ccc5cc6c(c7ccc(cc32)c4c57)c2ncccc2n6-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ REN P00797 7/20 0.37
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ LOXL3 P58215 1/20 0.35
▸ LOXL2 Q9Y4K0 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTT P42858 2/20 0.34
▸ GMNN O75496 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14329583 0.92 ALDH1A1 (0.35) KDM4EATML3MBTL1RENTSHR
SCHEMBL14329605 0.92 KDM4E (0.41) KDM4EATML3MBTL1RENPDE4A
SCHEMBL14330605 0.91 REN (0.35) KDM4EATML3MBTL1RENPDE4A
SCHEMBL14329584 0.90 KDM4E (0.42) KDM4EATML3MBTL1RENPDE4A
SCHEMBL14329618 0.90 KDM4E (0.33) KDM4EL3MBTL1RENTSHRHTT
SCHEMBL14329590 0.89 TOP1 (0.34) KDM4EL3MBTL1RENTSHRALDH1A1
SCHEMBL14329606 0.89 REN (0.31) KDM4EATML3MBTL1REN
SCHEMBL14329597 0.88 MAPK10 (0.38) KDM4EL3MBTL1TSHRALDH1A1HTT
SCHEMBL14329580 0.88 HPGD (0.36) KDM4EL3MBTL1RENHTTLMNA
SCHEMBL14329610 0.88 ALDH1A1 (0.33) KDM4EATML3MBTL1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-8771844-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-07-08 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326135-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D KDM4E 3157/4885ATM 2677/4885L3MBTL1 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback